DR. KING Y LEE, M.D.
Medical Practice at 74 St, Shawnee Mission, KS
License number
Kansas 0417607
Category
Medical Practice
Type
Ophthalmology
Address
Address
8901 W 74Th St STE 385, Shawnee Mission, KS 66204
Phone
(913) 362-7800
(913) 362-7899 (Fax)
(913) 362-7899 (Fax)
Personal information
See more information about KING Y LEE at radaris.comName
Address
Phone
905 Emery Rd, Laurence, KS 66044
Organization information
See more information about KING Y LEE at bizstanding.comKing Y Lee MD
5825 Pembroke Ct, Mission Hills, KS 66208
Categories:
Ophthalmology Physicians & Surgeons, Optometrists, Physicians & Surgeons
Phone:
(913) 362-7800 (Phone)
Payment options:
American Express, MasterCard, VISA
King Y Lee Md
8901 W 74 St #385, Shawnee Mission, KS 66204
Industry:
Medical Practice
Description:
King Y Lee Md is a Medical Practice company located in 8901 W 74th St # 385, Shawnee Mission, Kansas, United States.
Professional information
Dr. King Y Lee, Shawnee Mission KS - MD (Doctor of Medicine)
Address:
King Y Lee
8901 W 74Th St SUITE 385, Shawnee Mission 66204
(913) 362-7800 (Phone), (913) 362-7899 (Fax)
8901 W 74Th St SUITE 385, Shawnee Mission 66204
(913) 362-7800 (Phone), (913) 362-7899 (Fax)
Hospitals:
King Y Lee
8901 W 74Th St SUITE 385, Shawnee Mission 66204
Menorah Medical Center
5721 West 119Th St, Overland Park 66209
8901 W 74Th St SUITE 385, Shawnee Mission 66204
Menorah Medical Center
5721 West 119Th St, Overland Park 66209
Education:
Medical Schools
University Of Arkansas College Of Medicine
University Of Arkansas College Of Medicine
Method Of Treatment Of Macular Degeneration
US Patent:
5632984, May 27, 1997
Filed:
Sep 28, 1994
Appl. No.:
8/314534
Inventors:
Vernon G. Wong - Rockville MD
King Y. Lee - Mission KS
Jerry B. Gin - Sunnyvale CA
King Y. Lee - Mission KS
Jerry B. Gin - Sunnyvale CA
Assignee:
Oculex Pharmaceuticals, Inc. - Sunnyvale CA
International Classification:
A61K 3821
US Classification:
424 854
Abstract:
Intraocular administration of drugs such as. alpha. -2a interferon is employed in the treatment of age-related macular degeneration. Intraocular administration obviates the side effects associated with systemic administration, concentrates the drug at the site of the disease, and, where microcapsules are employed, provides continuous, long-lasting treatment.